IX.REFERÊNCIAS BIBLIOGRÁFICAS:
De acordo com:
ACOSTA-SERRANO, A.; ALMEIDA, I.C.; FREITAS-JUNIOR., L.H,
YOSHIDA, N.; SCHENKMAN, S. The mucin-like glycoprotein super-family of
Trypanosoma cruzi: structure and biological roles. Mol. Biochem. Parasitol.
v.114, n.2, p.143-50, 2001.
AFFRANCHINO, J.L.; IBANEZ, C.F.; LUQUETTI, A.O. ; RASSI, A., REYES,
M.B.; MACINA, R.A .; ASLUND, L.; PETTERSSON, U.; FRASCH, A.C.;.
Identification of a Trypanosoma cruzi antigen that is shed during the acute
phase of Chagas' disease. Mol Biochem Parasitol. v.15;34(3) p.221-8. May
1989.
ALMEIDA, I.C.; FERGUSON, M.A.; SCHENKMAN, S.; TRAVASSOS, L.R.;
Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas'
disease recognize novel O-linked oligosaccharides on mucin-like
glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem
J. v. 15;304 ( Pt 3) p.793-802 Dec 1994.
ANDRADE, A. L.; ZICKER, F.; MARTELLI, C.M. An epidemiological
approach to study congenital Chagas' disease Cad Saude Publica. 1994;
v.10l (2), p.345-51. Mar 19 Epub 2004.
BARRET, M.P. The trypanossomiases. The Lancet. v. 362, p. 1469-1480,
Novembro, 2003.
BITTENCOURT, A.L., ALTEMANI, A.M., LANA, A.M. Immunohistochemical
characterization of the inflammatory infiltrate in placental Chagas' disease: a
qualitative and quantitative analysis. Am J Trop Med Hyg;v.62 (2):319-24.
BRENER, Z.; ANDRADE, A.Z.; BARRAL-NETTO, M. Trypanosoma cruzi e Doença de Chagas. 2ª Edição. Rio de Janeiro. Guanabara Koogan S.A,
Cap.17., p. 345 – 372, 2000.
BRENER, Z.; GAZZINELLI, R. T. Immunological control of Trypanosoma
cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy
Immunol,v.114(2):103-10, Oct 1997.
BRIONES, M.R.; EGIMA, C.M.; SCHENKMAN, S.. Trypanosoma cruzi
trans-sialidase gene lacking C-terminal repeats and expressed in epimastigote
forms. Mol Biochem Parasitol;70(1-2):9-17. . Mar. 1995
BRITTO, C.; CARDOSO, M. A., WINCKER, P., MOREL, C.M. A simple
protocol for the physical cleavage of Trypanosoma cruzi kinetoplast DNA
present in blood samples and its use in polymerase chain reaction
(PCR)-based diagnosis of chronic Chagas disease. Mem Inst Oswaldo
Cruz;v.88(1):171-2, Jan-Mar, 1993.
BRITTO, C.; SILVEIRA, C., CARDOSO, M.A., MARQUES, P., LUQUETTI,
A.; MACEDO, V.; FERNANDES, O. Parasite persistence in treated chagasic
patients revealed by xenodiagnosis and polymerase chain reaction. Mem
Inst Oswaldo Cruz ;v.96(6):823-6. Aug, 2001.
CAMARGO, M. E. Development in the etiologic diagnosis of Chagas
disease. Mem Inst Oswaldo Cruz.;v.94 (1):281-2, 1999.
CAMARGO, M. E., SILVA, G.R, CASTILHO, E. A, SILVEIRA, A. C. Inquérito
Sorológico da Prevalência da Infecção Chagásica no Brasil, 1975/1980.
Rev. Inst. Med. Trop. São Paulo. v.26 (4), P. 192-204, Julho - agosto,
CAMARGO, M.E.; AMATO-NETO, V.. Anti-Trypanosoma cruzi IgM
antibodies as serological evidence of recent infection. Rev Inst Med Trop
Sao Paulo.;v.6(4) p.200-2. Jul-Aug,1974.
CAMPETELLA, O.; SANCHEZ, D.; CAZZULO, J.J.; FRASCH, A.C.; A
superfamily of Trypanosoma cruzi surface antigens. Parasitol Today.; v.
8(11) p.378-381. Nov. 1992.
CARLIER, Y.; TORRICO, F. Congenital infection with Trypanosoma cruzi:
From mechanisms of transmission to strategies for diagnosis and control.
Rev. Soc. Bras. Med. Trop. v. 36 (6): p. 767-771, nov.dez, 2003.
CAZZULO, J. J.; FRASH, A. C. C. SAPA/Trans-sialidase and cruzipain: two
antigens from Trypanossoma cruzi contain immunodominant but
enzimatically inactive domains. . FASEB J. Maryland v. 6, p.
3259-3264.1992.
CERISOLA, J. A.; FATALA, CHABEN, M.; LAZZARI, J.O. Hemagglutination
test for the diagnosis of Chagas' disease. Prensa Med Argent.
v.24(49)p.1761-7. Aug,1962.
CHAGAS, C. Nova entidade mórbida do Homem. Brasil Médico. Ano XXIV
n.43, p.423-428, 1910.
CHAGAS, C. Nova entidade mórbida do homem. Resumo geral de estudos
etiológicos e clínicos. Mem. Inst. Osvaldo Cruz. Rio de Janeiro. v.3,
p.219-275, 1911.
CHAGAS, C. Nova tripanossomíase humana. Estudos sobre a morfologia e
o ciclo evolutivo do Schizotrypanum cruzi. Mem. Inst. Osvaldo Cruz Rio de
CHIARI, E. Chagas disease diagnosis using polymerase chain reaction,
hemoculture and serologic methods. Mem Inst Oswaldo Cruz.;v.94 Suppl
1:p.299-300, 1999.
CIMERMAN, B.; CIMERMAN, S.; Parasitologia Humana e seus
fundamentos gerais. 1ª Edição. São Paulo. Editora Atheneu,. Cap. 11. p.
81 – 111, 1999.
COLLI, W., ALVES, M.J.; Relevant glycoconjugates on the surface of
Trypanosoma cruzi. .Mem Inst Oswaldo Cruz. v.94, n.1, p.37-49, 1999.
CORRAL, R.S.; ALTCHEH, J.; ALEXANDRE, S.R.; GRINSTEIN, S.;
FREILIJ, H.; KATZIN, A.M.. Detection and characterization of antigens in
urine of patients with acute, congenital, and chronic Chagas' disease J Clin
Microbiol. v.34(8), p.1957-62.Aug. 1996.
COURA, J. R. Tripanossomose, Doença de Chagas. Endemias. Rev. Soc.
Bras. progr. Ciência. v.55 (1), p. 30-33, Jan- Mar. 2003.
COURA, J. R. Tripanossomose, Doença de Chagas. Endemias. Rev. Soc.
Bras. progr. Ciência. v..55 (1), p. 30-33, Jan- Mar. 2003.
CREMONA, L.M.L, CAMPETELLA, O; SANCHEZ, D.O; FRASCH, AC
Enzymically inactive members of the trans-sialidase family from
Trypanossoma cruzi display beta-galactose binding activity. Glycobiology
v.9,(5) p.581-587.1995.
CREMONA, M.,; SÁNCHEZ, D. O.,. FRASCH, A. C. C.; CAMPETELLA, O A
single tyrosine differenciates active and inactive Trypanossoma cruzi
DE MARCHI, C.R.; AMATO-NETO, V.; FEREIRA, C.S.; FERREIRA, A.W.
Doença de Chagas: Avaliação da sensibilidade e especificidade por Western
Blotting do antígeno de secreção e excreção de formas tripomastigotas.
Rev. Soc. Brás. De Méd. Trop.. v.37, p. 153, 2004 .Suplemento I. Resumo
apresentado no XL Congresso da Sociedade Brasileira de Medicina
Tropical.
DI NOIA, JM, BUSCAGLIA; CA, DE MARCHI; CR, ALMEIDA; IC, FRASCH;
AC. A Trypanosoma cruzi small surface molecule provides the first
immunological evidence that Chagas' disease is due to a single parasite
lineage. J. Exp. Méd.; v.195(4): 401-13; 18 Feb, 2002.
DIAS, J. C.; Doença de Chagas. In: CIMERMAN, B.; CIMERMAN, S.;
Parasitologia Humana e seus fundamentos gerais. 1ª Edição. São Paulo.
Editora Atheneu, Cap. 11. p. 81 – 111, 1999.
DIAS, J.C.; SCHONFIELD, C.J. Controle da transmissão Transfusional da
doença de Chagas nos Países do Cone Sul. Rev. Soc, Bras. de Medicina
Tropical. v.31 (4): 373-383, Jul-Ago 1998.
DIAS, J.C.; SILVEIRA, ªC; SCHOFIELD,C..J. The Impact of Chagas
Diesease Control in Latin Améria. Mem. Inst. Owaldo Cruz. v.97
(5):603-612. Jul.2002.
DUMONTEIL, E.; RUIZ-PIÑA, H; RODRIGUEZ-FÉLIX,E.;
BARRERA-PÉREZ, M.; RAMIREZ-SIERRA, M.J.; RABINOVICH, J.E.; MENU,F.
Re-infestation of Houses by Tratoma diminuta after inseticide aplications in the
Yucatán Península, México. Mem. Inst. Oswaldo CruzN. v.99(3): 253-256,
FERREIRA, A. W.; ÁVILA, S.L.M. Doença de Chagas. In: FERREIRA, A. W.;
ÁVILA, S. L. M. Diagnóstico Labortorial das Doenças Infecciosas e
Auto-Imunes. 2ª Edição. Rio de Janeiro. Editora Guanabara Koogan S.A,
2001.Cap.22., p. 241-249.
FERREIRA, A.W.; BELEM, Z.R.; LEMOS, E.A.; REED, S.G.;
CAMPOS-NETO, A. Enzyme-linked immunosorbent assay for serological diagnosis of
Chagas' disease employing a Trypanosoma cruzi recombinant antigen that
consists of four different peptides. J Clin Microbiol.;v.39(12), p.4390-5. Dec.
2001.
FERREIRA, M. U.; FORONDA, A. S.; SCHUMAKER, T. T. S. Trypanossoma
cruzi e a doença de Chagas. In: FERREIRA, M. U.; FORONDA, A. S.;
SCHUMAKER, T. T. S. Fundamentos Biológicos da Parasitologia
Humana. 1ª Edição. São Paulo. Editora Manole LTDA, 2003. Cap.4.
p.27-36.
FRADE, A. F.; FERREIRA, A. W.; SANTOS, F. N. D. Confirmação do
diagnóstico sorológico da doença de Chagas através dos resultados obtidos
no TESAcruzi. In: 38º Congresso Brasileiro de Patologia Clinica e Medicina
Laboratorial, 2004, Florianópolis-SC.
FRADE, A.F.; KUDO, M.E.; ARAÚJO, P.; LUQUETTI, A.L.; PRATA, A.;
FERREIRA, A.W. Soroprevalência da doença de Chagas em zonas rurais do
Brasil confirmadas por Western Blotting – “TESAcruzi” In: XVII
CONGRESSO BRASILEIRO DE PARASITOLOGIA., 2003, Rio de Janeiro –
RJ. Livro de Resumos: Epidemiologia das doenças parasitárias. , Rio de
FRADE, A.F.; LEMOS, E. A.; BECK, S. T.; LUQUETTI, A.L.; PRATA, A.;
FERREIRA, A.W. Avaliação do método de Western Blotting – TESAcruzi –
em amostras de sangue colhidas em papel de filtro, como confirmatório da
infecção chagásica. Rev. Soc. Bras. Med. Trop. v. 36 p.373, 2003.
Suplemento I. Resumo apresentado no XXXIX Congresso da sociedade
Brasileira de Medicina Tropical.
FRASCH, A.C. Functional diversity in the trans-sialidase and mucin families
in Trypanosoma cruzi. Parasitol Today. v.16, n.7, p.:282-6, 2000.
FUNASA, Elaboração de Projeto de melhoria habitacional para o controle da
doença de Chagas, Ministério da Saúde, Fundação Nacional de Saúde,
Ed. Acessória de comunicação e Educação em Saúde,Brasília-DF, 2004.
GIORDANO, R.; FOUTS, D.L.; TEWARI, D.; COLLI ,W.; MANNING, J.E.;
ALVES, M.J.; Cloning of a surface membrane glycoprotein specific for the
infective form of Trypanosoma cruzi having adhesive properties to laminin. J.
Biol. Chem.v.5;274(6):3461-8Feb. 1999.
GUHL, F.; JARAMILLO, C.; YOCKTENG, R.; VALLEJO, G.A.;
CARDENAS-ARROYO, F.. Trypanosoma cruzi DNA in human mummies. Lancet. v.10
(349/9062) p.1370. - May,1997.
GÜRTLER, R.E.; SEGURA, E.L.; COHEN, J.E. Congenital transmission of
Trypanossoma cruzi infection in Argentina. Emerg. Infec. Diseases. v.9 (1)
p.29-32. January, 2003.
HOUGTON, R.L.; BENSON, D.R.; REYNOLDS, L.; MCNEILL, P.; SLEATH,
P.; LODES, M.; SKEIKY, Y.A.W.; BADARO, R.; KRETLLI, A.U.; REED, S.G
A multi- Epitope Synthetic peptide and recombinant protein for the detection
of antibodies to Trypanossoma cruzi in radioimmunopreciptation – Confirmed
HOUGTON, R.L.; BENSON, D.R.; REYNOLDS, L.; MCNEILL, P.; SLEATH,
P.; LODES, M.; SKEIKY, Y.A.W.; BADARO, R.; KRETLLI, A.U.; REED, S.G.
Multi-epitope synthetic peptide and recombinant protein for detection of
antibodies to Trypanossoma cruzi in patients with treated or untreated
Chagas´disease. J. Inf. Dis. v.181, p.325-330, 2000.
JAZIN, E.E.; BONTEMPI, E.J.; SANCHEZ, D.O.; ASLUND, L.;
HENRIKSSON, J.; FRASCH, A.C.; PETTERSSON, U. Trypanosoma cruzi
exoantigen is a member of a 160 kDa gene family. Parasitology. v. 110 (Pt
1) p. 61-9. Jan. 1995.
JOINER, K.A.; DASILVA, W.D.; RIMOLDI, M.T.; HAMMER, C.H.; SHER, A.;
IPNIS, T.L Biochemical characterization of a factor produced by
trypomastigotes of Trypanosoma cruzi that accelerates the decay of
complement C3 convertases. J Biol Chem. v. 15;263(23) p.11327-35. Aug
1988.
KELM, S.; SCHAUER, R. Sialic acids in molecular and cellular interactions.
Int. Rev. Cytol. New York v. 175, p. 137-240.
KELM, S.; SCHAUER, R.; Sialic acids in molecular and cellular interactions.
Int Rev Cytol.;v. 175 p.137-240. 1997.
KESPER, N.J.; DE ALMEIDA, K.A.; STOLF, A.M.; UMEZAWA, E.S.
Immunoblot analysis of trypomastigote excreted-secreted antigens as a tool
for the characterization of Trypanosoma cruzi strains and isolates.
J.Parasitol;v. 86(4):862-7. Aug .2000.
KOLLIEN, A.H.; SCHAUB, G.A. The effect of azadirachtin on Blastocrithidia
triatomae and Trypanosoma cruzi in Triatoma infestans (Insecta, Hemiptera).
LANA, M., SILVEIRA PINTO, A.; BARNABE, C.; QUESNEY, V., NOEL, S.;
TIBAYRENC, M. Trypanosoma cruzi: compared vectorial transmissibility of
three major clonal genotypes by Triatoma infestans. Exp.
Parasitol..;v.90(1):20-5. Sep, 1998.
LANA, M.; TAFURI, W. L. Trypanossoma cruzi. In: NEVES, D. P. et. al
Parasitologia Humana 9ª Edição. São Paulo. Editora Atheneu, 1995. Cap.
10, p. 82– 114.
LANDIS, J.R; KOCH, G.G. The Mesurement of Observer Agreement for
Categorial Data Biometrics, vol. 33. Mar.1997.
LENZI, H.L.; OLIVEIRA, D.N.; LIMA, M.T.; GATTASS, C.R. Trypanosoma
cruzi: paninfectivity of CL strain during murine acute infection. Exp Parasitol,
v.84(1):16-27.Oct , 1996.
LEWINSOHN, R. The Discovery of Tripanossoma cruzi and of American
Tripanossomisasis. Trans.R. Soc. Trop Med. Hyg., Londres. v. 73, n.5,
p.513-523, 1979.
LUQUETTI, A.O., PONCE, C.; PONCE, E.; ESFANDIARI, J.; SCHIJMAN, A.;
REVOLLO, S.; ANEZ, N.; ZINGALES, B.; RAMGEL-ALADAO, R.;
GONZALEZ, A.; LEVIN, M.J.; UMEZAWA, E.S.; FRANCO DA SILVEIRA, J.
Chagas' disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a
rapid immunochromatographic assay with recombinant proteins of
Trypanosoma cruzi. Diagn Microbiol Infect Dis, v.46(4):265-71. Aug, 2003.
MAGDESIAN, M.H.; GIORDANO, R.; ULRICH, H.; JULIANO, M.A.;
JULIANO, L.; SCHUMACHER, R.I.; COLLI, W.; ALVES, M.J.; Infection by
Trypanosoma cruzi. Identification of a parasite ligand and its host cell
MANSILLA, M.; ROCHA, M.C.; SARUBBI, M.A. Chagas congênito,
presentation de um caso clinico y revision bibliográfica. Rev. Hosp. Mat.
Inf. Rámon Sardá. v.18 (1) p.29-35. 1999.
MATSUMOTO, T.K.; HOSHINO-SHIMIZU, S.; NAKAMURA, P.M.;
ANDRADE, H.F. Jr.; UMEZAWA, E.S. High resolution of Trypanosoma cruzi
amastigote antigen in serodiagnosis of different clinical forms of Chagas'
disease. J Clin Microbiol. v.31(6):1486-92. Jun, 1993.
MENDES, R.P.; HOSHINO-SHIMIZU, S.; MOURA DA SILVA, A.M.; MOTA,
I.; HEREDIA, R.A.; LUQUETTI, A.O.; LESER, P.G. Serological diagnosis of
Chagas' disease: a potential confirmatory assay using preserved protein
antigens of Trypanosoma cruzi. J Clin Microbiol;v.35(7):1829-34.Jul, 1997.
MILLAR, A.E.; WLEKLINSKI-LEE, M.; KAHN, S.J.; The surface protein
superfamily of Trypanosoma cruzi stimulates a polarized Th1 response that
becomes anergic. J Immunol. v.15;162(10), p.6092-9. May 1999.
MONCAYO, A. Chagas disease: current epidemiological trends after the
interruption of vectorial and transfusional transmission in the Southern Cone
countries. Mem Inst Oswaldo Cruz; v.98(5):577-91. Epub 2003 Sep 08. Jul,
2003.
MOREL, M.C.; LAZDINS, J. Chagas Disease, Nature; Oct. 2003 vol. 1;p.14.
Oct. 2003. Disponível em: < http://www.nature.com/index.html> Acesso em
15 jul.2004.
MOSER, D.R.; KIRCHHOFF, L.V.; DONELSON, J.E.. Detection of
Trypanosoma cruzi by DNA amplification using the polymerase chain
NORRIS, K.A.; SCHRIMPF, J.E.; SZABO, M.J.. Identification of the gene
family encoding the 160-kilodalton Trypanosoma cruzi complement
regulatory protein. Infect Immun.;v .65(2) p.349-57. Feb. 1997.
OKUMURA, M.; APARECIDA, DOS SANTOS, V.; CAMARGO, M.E.;
SCHULTZ, R.; ZUGAIB, M.. Prenatal diagnosis of congenital Chagas'
disease (American trypanosomiasis). Prenat Diagn. p.24(3) p.179-81Mar.
2004.
OLEMANN, W.M.; TEIXEIRA, M.D.; VERÍSSIMO DA COSTA, G.C.;
BORGES-PEREIRA, J.; DE CASTRO, J.A.; COURA, J.R.; PERALTA, J.M.
Evalution of theree comercional enzyme-linked immunosorbent assay for
diagnosis of Chagas disease. J.Clin. Microbiol. 36:2423 – 2427, 1998.
PAHO/ TDR 2002. Chagas Disease (American Tripanossomiasis).
Disponível em: <http://www.paho.org/english/hcp/hct/dch/chagas.htm>
Acesso em 12 Mai 2003.
PESSÔA, S.B.; MARTINS. A. V.; Doença de Chagas. Histórico –
Distrubuição Geográfica – Transmissão Patogenia – Formas Clínicas –
Imunidade. In: PESSÔA, S.B.; MARTINS. A. V. Parasitologia Médica. 11ª
Edição.Rio de Janeiro. Editora: Guanabara Koogan S.A,. Cap. 13. p.
143-163, 1982.
POLLEVICK, G.D; AFFRANCHINO, J.L.; FRASCH, A.C.; SANCHEZ, D.O.;
The complete sequence of a shed acute-phase antigen of Trypanosoma
cruzi. Mol Biochem Parasitol.;v.47(2):247-50. Aug. 1991.
PRATA, A. Clinical and Epidemiological aspects of Chagas Disease. The
PUNUKOLLU, G.; GOUDA, R. M; KAN, I. A. Early twentieth century
descriptions of the Chagas heart disease.
Int. J. Cardiol.; v. 95(2-3), p.347-9, Jun. 2004.
RABELLO, A; LUQUETTI, A.O.; MOREIRA, E.F.; GADELHA, M.D.E. F.;
DOS SANTOS, J.A.; DE MELO, L.; SCHWIND, P.. Serodiagnosis of
Trypanosoma cruzi infection using the new particle gel
immunoassay--ID-PaGIA Chagas Mem. Inst Oswaldo Cruz. v.94(1), p.77-82. Jan-Feb; 1999.
REICHE, E.M.; INOUYE, M.M.; BONAMETTI, A.M.; JANKEVICIUS, J.V.
Congenital Chagas Disease: epidemiology, laboratorial diagnosis, prognosis
and treatment. J Pediatr. (Rio J), v.72(3):125-32 .May-Jun, 1996.
Reunión Intergubernamental INCOSUR/ Chagas, Santiago, Chile, Marzo,
2003. Iniciativa del Cono Sur para controlar e eliminar la enfermedad de
Chagas Disponível em:
http://www.paho.org/Spanish/AD/DPC/CD/incosur.htm Acesso em: 25
set.2004.
SÁNCHEZ-GULLÉN, M.C.; BARBABÉ, C.; GUÉGAN, J.F.; TIBAYRENC, M.;
VELÁSQUEZ-ROJAS, M.; MARTÍNEZ-MUNGUÍA, J.; SALGADO-ROSAS,
H.; TORRES-RASGADO, E.; ROSAS-RAMÍREZ, M.I.; PÉREZ-FUENTES,R.
High prevalence Anti-Trypanossoma cruzi antibodies, among blood donors in
the state of Puebla, a non-endemic área of México. Mem. Inst. Oswaldo
Cruz. v.97 (7): 947-952, Out. 2002.
SCHENKMAN, S.; EICHINGER, D.; PEREIRA, M.E; NUSSENZWEIG, V.
Structural and functional properties of Trypanosoma trans-sialidase. Annu
Rev Microbiol.;v.48 p.499-523, 1994.
SCHENKMAN, S.; JIANG, M.S.; HART, G.W.; NUSSENZWEIG, V. A novel
epitope required for invasion of mammalian cells. Cell. 28 v.;65 (7):1117-25.
Jun.1991.
SCHENKMAN, S.; JIANG, M.S.; HART, G.W.; NUSSENZWEIG, V. A novel
cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific
epitope required for invasion of mammalian cells. Cell. v. 28;65(7)
p.1117-25. Jun 1991.
SCHOFIELD; C.J. Eradication of Triatoma infestans: a new regional
programme for southern Latin America. Ann Soc Belg Med Trop. v.72
Suppl 1:69-70 – 1994.
SCHUMUNIS, G. A. et al. Risk for transfusion- transmitted infectious
diseases in Central and South America. Em. Infec. Diseases. New York. v.
4, (1), p.5-11Jan-Mar 1998.
SILVA, R.A; CARVALHO, M.E.; RODRIGUES, V.L.C.C Doença de Chagas –
Profissionais da saúde Sucen. Disponível em:
http://www.sucen,sp.gov.br/doenca/chagas/texto-chagas-pro1b.htm . Acesso
em 18 out.2004.
SILVEIRA, A.C. Situação do controle da transmissão vetorial da Doença de
Chagas nas Américas. Cad. Saúde Pública. v.16 (2) 35-42,2000.
SILVEIRA, A.C.; VINHAES, M.C. Chagas disease: the epidemiological and
control aspects. Rev Soc Bras Med Trop v.31 (2) p.15-60.; 1998.
SILVEIRA, J.F.; UMEZAWA; E.S.; LUQUETTI, A.O. Chagas disease:
recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends
SILVEIRA-LACERDA, E.P.; SILVA, A.G.; JUNIOR, S.F.; SOUZA, M.A.
KESPER, N.; BOTELHO-FILHO, A., UMEZAWA, E.S. Chagas' disease:
application of TESA-blot in inconclusive sera from a Brazilian blood bank.
Vox Sang v.87(3) p.204-7. Oct; 2004
SILVEIRA-LACERDA, E.P.; UMEZAWA, E.S. Hemoterapia e a doença de
Chagas. Avaliação do TESA-Blot no diagnóstico da doença de Chagas. Rev.
Soc. Bras. Méd. Trop. V.35, p.155-7. Suplemento III. Tema apresentado na
XVIII Reunião anual da pesquisa aplicada em doença de Chagas.
SOUZA, S.L.; CAMARGO, M.E. The use of filter paper blood smears in a
practical fluorescent test for American Trypanosomiasis serodiagnosis. Rev
Inst Med Trop Sao Paulo; v.8(6)p.255-8. . Nov-Dec,1966.
STURM, N.R.; DEGRAVE, W.; MOREL, C.; SIMPSON, L.. Sensitive
detection and schizodeme classification of Trypanosoma cruzi cells by
amplification of kinetoplast minicircle DNA sequences: use in diagnosis of
Chagas' disease. Mol Biochem Parasitol. V.15;33(3)p.205-14 Mar1989.
TAKLE, G. B.; SNARY, D. South American trypanossomiasis (Chagas´
disease) In: WARREN, K. Immunology and Molecular Biology of
Parasitic Infections. 3rd Edition. Boston. Ed. Blackwell Scientific
Publications,. Cap.11,p.213-236, 1992.
TDR.(2002) Chagas Disease/ Disease Information. Disponível em:
http://www.who.int/tdr/diseases/chagas/diseaseinfo.htm Acesso em 10 abril
2004.
TEIXEIRA, M.G., BORGES-PEREIRA, J.; NETIZERT, E.; SOUZA, M.L.;
PERALTA, J.M. Development and evaluation of an enzyme linked
immunotransfer blot technique for serodiagnosis of Chagas' disease. Trop
TORRICO, F.; ALONSO-VEG, C.; SUAREZ, E.; RODRIGUEZ, P.;
TORRICO, M.C.;DRAMAIX, M.; TRUYENS, C.; CARLIER, Y. Maternal
Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of
congenitally infected and non-infected newborns in Bolivia. Am J Trop Med
Hyg.; v.70(2), p.201-9. 2004.
UMEZAWA, E.S.; NASCIMENTO, M.S.; KESPER Jr, N.; COURA, J.R.;
BORGES-PEREIRA, J.; JUNQUEIRA, C.V.; CAMARGO, M.E.; Immunoblot
assay using excreted-secreted antigens of Tripanossoa cruzi in
serodiagnosis of congenital, acute, and cronic Chagas´disease. J. Clin.
Microbiol., v.34 (9) p.2143-2147, 1996.
UMEZAWA, E.S.; BASTOS, S.F.; CAMARGO, M.E.; YAMAUCHI, L.M.;
SANTOS, M.R.; GONZALEZ, A.; ZINGALES, B.; LEVIN, M.J.; SOUSA, O.;
RANGEL-ALDAO, R.; DA SILVEIRA; J.F. Evaluation of recombinant
antigens for serodiagnosis of Chagas' disease in South and Central America.
J. Clin. Microbiol; v.37(5):1554-60. May 1999.
UMEZAWA, E.S.; LUQUETTI, A.O.; LEVITUS, G.; PONCE, C.; PONCE, E.;
HENRIQUEZ, D.; REVOLLO, S.; ESPINOZA, B.; SOUZA, O.; KHAN, B. DA
SILVEIRA, J.F. Serodiagnosis of chronic and acute Chagas' disease with
Trypanosoma cruzi recombinant proteins: results of a collaborative study in
six Latin American countries. J Clin Microbiol ;v.42(1):449-52. Jan, 2004.
UMEZAWA, E.S.; NASCIMENTO, M.S.; STOLF, A.M.;Enzyme-linked
immunosorbent assay with Trypanosoma cruzi excreted-secreted antigens
(TESA-ELISA) for serodiagnosis of acute and chronic Chagas' disease.
Diagn Microbiol Infect Dis; v.39(3) p.169-76. . Mar. 2001.
UMEZAWA, E.S.; SHIKANAI-YASUDA, M.A.; DA SILVEIRA, J.F.; COTRIM,
P.C.; PARANHOS, G.; KATZIN, A.M.. Trypanosoma cruzi: detection of a
with an immunodominant repetitive antigen. Exp Parasitol.;v.76(4) p.352-7.
Jun, 1993.
UMEZAWA, E.S.; SILVEIRA, J.F. Serological diagnosis of Chagas disease
with purified and defined Trypanosoma cruzi antigens. Mem. Inst. Oswaldo
Cruz; v.94.( 1):285-8. 1999.
VALENTE, S.A.S; VALENTE, V.C.; FRAHIA NETO, H. Consideratiosn on the
epidemiology and transmission of Chagas disease in the Brasilian Amazon.
Mem. Inst. Oswaldo Cruz. V.94 91):395-398, 1998.
VAN VOORHIS, W.C.; EISEN, H. Fl-160. A surface antigen of Trypanosoma
cruzi that mimics mammalian nervous tissue. J Exp Med. v. 1;169(3)
p.641-52. Mar 1989.
VARKI A. Sialic acids as ligands in recognition phenomena. FASEB J.
v.11(4) p.248-55. Mar. 1997.
VARKI, A. Sialic acids as ligands in recognition phenomena. FASEB J.
Maryland v.11, p.248-255. Mar, 1997.
VINHAES, M. C., DIAS, J. C. P. Doença de Chagas no Brasil. Cad. Saúde
Pública, Rio de Janeiro, v.16 (.2), p. 7-12, 2000.
VOLLER, A.; DRAPER, C.; BIDWELL, D.E.; BARTLETT, A. Microplate
enzyme-linked immunosorbent assay for chagas' disease Lancet .v. 22;1
(7904) p.426-8. Feb, 1975.
WESTON, D.; L.A.; FLAMME, A.C.; VAN VOORHIS, W.C.; Expression of
Trypanosoma cruzi surface antigen FL-160 is controlled by elements in the 3'
untranslated, the 3' intergenic, and the coding regions. Mol Biochem
WHO (2004) Chagas disease. Disponível em
http://www.who.int/topics/chagas_disease/en/ Acesso em maio, 2004.
WIZEL, B.; NUNES, M.; TARLETON, R.L.; Identification of Trypanosoma
cruzi trans-sialidase family members as targets of protective CD8+ TC1
responses. J Immunol. v. 15; 159(12): p.6120-30. Dec. 1997.
YASUDA, S.A.; LINDOSO, A.B.P. Chronic Chagas disease: from
xenodiagnosis and hemoculture to polymerase chain reaction. Rev. Saude
Pub; 37(1); 107-15, Jun 2003.
YOSHIDA, N.; DORTA, M.L, FERREIRA, A.T; OSHIRO, M.E.; MORTARA,
R.A.; ACOSTA-SERRANO,. A, FAVORETO JUNIOR, S. Removal of sialic
acid from mucin-like surface molecules of Trypanosoma cruzi metacyclic
trypomastigotes enhances parasite-host cell interaction. Mol Biochem
Parasitol. v. 84 (1) p.57-67Jan; .1997.
ZAIDENBERG, M. Congenital Chagas' disease in the province of Salta,
Argentina, from 1980 to 1997 Rev Soc Bras Med Trop.; v.32 (6),
p.689-95.Nov-Dec, 1999.
ZINGALES, B; STOLF, B.S.; SOUTO, R.P.; FERNANDES, O.; BRIONES,
M.R. Epidemiology, biochemistry and evolution of Trypanosoma cruzi
lineages based on ribosomal RNA sequences. Mem Inst Oswaldo Cruz.
